248 related articles for article (PubMed ID: 17541528)
1. [Blood glucose control in type 2 diabetes. Basic requirements for reducing vascular complications].
Seissler J
Internist (Berl); 2007 Jul; 48(7):676, 678-80, 682 passim. PubMed ID: 17541528
[TBL] [Abstract][Full Text] [Related]
2. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
Cavalot F
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
[TBL] [Abstract][Full Text] [Related]
3. Which patients should be evaluated for blood glucose variability?
Candido R
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():9-12. PubMed ID: 24034514
[TBL] [Abstract][Full Text] [Related]
4. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.
Monnier L; Colette C; Owens DR
Diabetes Metab Res Rev; 2009 Jul; 25(5):393-402. PubMed ID: 19437415
[TBL] [Abstract][Full Text] [Related]
5. What does postprandial hyperglycaemia mean?
Heine RJ; Balkau B; Ceriello A; Del Prato S; Horton ES; Taskinen MR
Diabet Med; 2004 Mar; 21(3):208-13. PubMed ID: 15008828
[TBL] [Abstract][Full Text] [Related]
6. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
Bonora E
Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
[TBL] [Abstract][Full Text] [Related]
7. Prandial hyperglycemia: is it important to track and treat?
Hanefeld M; Schaper F
Curr Diab Rep; 2005 Oct; 5(5):333-9. PubMed ID: 16188167
[TBL] [Abstract][Full Text] [Related]
8. Role of postprandial hyperglycaemia in cardiovascular disease in diabetes.
Yamagishi SI; Nakamura K; Matsui T; Ueda SI; Imaizumi T
Int J Clin Pract; 2007 Jan; 61(1):83-7. PubMed ID: 17229182
[TBL] [Abstract][Full Text] [Related]
9. Optimizing diabetes management through glucose profiling: a case-based approach.
Streja DA
Prim Care Diabetes; 2008 Dec; 2(4):167-73. PubMed ID: 18786873
[TBL] [Abstract][Full Text] [Related]
10. Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide.
Kitasato L; Tojo T; Hatakeyama Y; Kameda R; Hashikata T; Yamaoka-Tojo M
Cardiovasc Diabetol; 2012 Jun; 11():79. PubMed ID: 22748110
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance, pathogenesis, and management of postprandial hyperglycemia.
Gerich JE
Arch Intern Med; 2003 Jun; 163(11):1306-16. PubMed ID: 12796066
[TBL] [Abstract][Full Text] [Related]
12. Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.
Monnier L; Colette C
Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S9-6S15. PubMed ID: 26774019
[TBL] [Abstract][Full Text] [Related]
13. Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice.
Boutati EI; Raptis SA
Diabetes Metab Res Rev; 2004; 20 Suppl 2():S13-23. PubMed ID: 15551342
[TBL] [Abstract][Full Text] [Related]
14. Postprandial glycemia and cardiovascular disease in diabetes mellitus.
Wajchenberg BL
Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):212-21. PubMed ID: 17505628
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a patient education booklet (SimpleStart) effect on postprandial glucose control in type 2 diabetes.
King AB; Wolfe GS; Armstrong DU
Diabetes Technol Ther; 2007 Jun; 9(3):241-5. PubMed ID: 17561794
[TBL] [Abstract][Full Text] [Related]
16. Postprandial hyperglycaemia: noxious effects on the vessel wall.
Hanefeld M
Int J Clin Pract Suppl; 2002 Jul; (129):45-50. PubMed ID: 12166606
[TBL] [Abstract][Full Text] [Related]
17. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
Giugliano D; Ceriello A; Razzoli E; Esposito K
Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
[TBL] [Abstract][Full Text] [Related]
18. Personalizing treatment in type 2 diabetes: a self-monitoring of blood glucose inclusive innovative approach.
Ceriello A; Gallo M; Armentano V; Perriello G; Gentile S; De Micheli A;
Diabetes Technol Ther; 2012 Apr; 14(4):373-8. PubMed ID: 22216963
[TBL] [Abstract][Full Text] [Related]
19. [Glycemic control and cardiovascular benefit: What do we know today?].
Hanefeld M; Schönauer M; Forst T
Dtsch Med Wochenschr; 2010 Feb; 135(7):301-7. PubMed ID: 20146161
[TBL] [Abstract][Full Text] [Related]
20. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.
Abrahamson MJ
Arch Intern Med; 2004 Mar; 164(5):486-91. PubMed ID: 15006824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
